TMC Life Sciences Berhad Statistics

Total Valuation

TMC Life Sciences Berhad has a market cap or net worth of MYR 914.49 million. The enterprise value is 928.59 million.

Market Cap	914.49M
Enterprise Value	928.59M

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	Dec 5, 2024

Share Statistics

TMC Life Sciences Berhad has 1.74 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.74B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.87%
Owned by Institutions (%)	1.41%
Float	308.63M

Valuation Ratios

The trailing PE ratio is 22.53.

PE Ratio	22.53
Forward PE	n/a
PS Ratio	2.64
PB Ratio	1.03
P/TBV Ratio	n/a
P/FCF Ratio	18.51
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.25, with an EV/FCF ratio of 18.79.

EV / Earnings	22.84
EV / Sales	2.68
EV / EBITDA	11.25
EV / EBIT	16.19
EV / FCF	18.79

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.23.

Current Ratio	2.66
Quick Ratio	2.51
Debt / Equity	0.23
Debt / EBITDA	2.49
Debt / FCF	4.15
Interest Coverage	5.60

Financial Efficiency

Return on equity (ROE) is 4.65% and return on invested capital (ROIC) is 3.30%.

Return on Equity (ROE)	4.65%
Return on Assets (ROA)	3.03%
Return on Capital (ROIC)	3.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.29
Inventory Turnover	16.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.52%
50-Day Moving Average	0.55
200-Day Moving Average	0.65
Relative Strength Index (RSI)	38.12
Average Volume (20 Days)	342,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TMC Life Sciences Berhad had revenue of MYR 346.42 million and earned 40.65 million in profits. Earnings per share was 0.02.

Revenue	346.42M
Gross Profit	138.02M
Operating Income	57.36M
Pretax Income	52.62M
Net Income	40.65M
EBITDA	80.28M
EBIT	57.36M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 191.13 million in cash and 205.23 million in debt, giving a net cash position of -14.10 million or -0.01 per share.

Cash & Cash Equivalents	191.13M
Total Debt	205.23M
Net Cash	-14.10M
Net Cash Per Share	-0.01
Equity (Book Value)	888.03M
Book Value Per Share	0.51
Working Capital	163.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.76 million and capital expenditures -25.35 million, giving a free cash flow of 49.41 million.

Operating Cash Flow	74.76M
Capital Expenditures	-25.35M
Free Cash Flow	49.41M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 39.84%, with operating and profit margins of 16.56% and 11.73%.

Gross Margin	39.84%
Operating Margin	16.56%
Pretax Margin	15.19%
Profit Margin	11.73%
EBITDA Margin	23.17%
EBIT Margin	16.56%
FCF Margin	14.26%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 4.18%.

Dividend Per Share	0.02
Dividend Yield	4.18%
Dividend Growth (YoY)	204.35%
Years of Dividend Growth	2
Payout Ratio	35.99%
Buyback Yield	n/a
Shareholder Yield	4.18%
Earnings Yield	4.44%
FCF Yield	5.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TMC Life Sciences Berhad has an Altman Z-Score of 3.24.

Altman Z-Score	3.24
Piotroski F-Score	n/a